PELO expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.202200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.969200E-01
Normal-vs-Stage2
8.136800E-01
Normal-vs-Stage3
4.709400E-01
Normal-vs-Stage4
6.322600E-01
Stage1-vs-Stage2
8.194600E-01
Stage1-vs-Stage3
5.744000E-01
Stage1-vs-Stage4
4.275400E-01
Stage2-vs-Stage3
4.503200E-01
Stage2-vs-Stage4
2.731200E-01
Stage3-vs-Stage4
3.224000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.908000E-01
Normal-vs-AfricanAmerican
7.832800E-01
Normal-vs-Asian
9.033600E-01
Caucasian-vs-AfricanAmerican
8.909400E-01
Caucasian-vs-Asian
8.252000E-01
AfricanAmerican-vs-Asian
8.319800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.963000E-01
Normal-vs-Female
8.640400E-01
Male-vs-Female
7.321200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.537400E-01
Normal-vs-Age(41-60Yrs)
6.628600E-01
Normal-vs-Age(61-80Yrs)
6.074800E-01
Normal-vs-Age(81-100Yrs)
5.637800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.276600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.432200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.138600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.099690E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.357900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.329400E-01
Normal-vs-Daily Drinker
4.924200E-01
Normal-vs-Weekly Drinker
6.831000E-01
Normal-vs-Occasional Drinker
8.615200E-01
Normal-vs-Social Drinker
9.143600E-01
Non Drinker-vs-Daily Drinker
9.488000E-01
Non Drinker-vs-Weekly Drinker
8.142800E-01
Non Drinker-vs-Occasional Drinker
1.342250E-01
Non Drinker-vs-Social Drinker
1.664630E-01
Daily Drinker-vs-Weekly Drinker
8.504600E-01
Daily Drinker-vs-Occasional Drinker
1.524970E-01
Daily Drinker-vs-Social Drinker
1.612610E-01
Weekly Drinker-vs-Occasional Drinker
3.366800E-01
Weekly Drinker-vs-Social Drinker
3.683800E-01
Occasional Drinker-vs-Social Drinker
8.474800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.250040E-01
Normal-vs-Grade 2
6.104900E-03
Normal-vs-Grade 3
2.838000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.176900E-03
Grade 1-vs-Grade 3
4.610400E-02
Grade 1-vs-Grade 4
1.250040E-01
Grade 2-vs-Grade 3
4.620800E-01
Grade 2-vs-Grade 4
6.104900E-03
Grade 3-vs-Grade 4
2.838000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.800200E-01
Normal-vs-NonDiabetic
8.203800E-01
Diabetic-vs-NonDiabetic
5.758600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.655200E-01
Normal-vs-NoPancreatitis
8.093600E-01
Pancreatitis-vs-NoPancreatitis
3.427400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.673000E-01
Normal-vs-N1
8.002400E-01
N0-vs-N1
6.848600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.538000E-01
Normal-vs-TP53-NonMutant
5.904600E-01
TP53-Mutant-vs-TP53-NonMutant
1.110630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
